Navigation Links
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
Date:1/23/2010

Human trials soon to begin which could lead to new treatments for millions of women suffering from fibroid tumors

Nashville, TN (Vocus) January 22, 2010 -- Researchers at Meharry Medical College have discovered that an extract of green tea could be used as a treatment for uterine fibroids, a disease that affects forty percent of reproductive age women.

An article published this week in the American Journal of Obstetrics and Gynecology, by Meharry’s Director of Clinical Research, Dr. Ayman Al-Hendy and his team of investigators, stated that an extract of green tea has the ability to kill human leiomyoma cells in tissue cultures and can eradicate fibroid lesions in animal models.

Al-Hendy said if the treatment is found to be effective in humans it can change the lives of millions of women who are currently faced with hysterectomy as their only treatment option.

“If we can prove this compound is effective, millions of women can start self treatment and self management,” he said.

The symptoms of uterine fibroids are often debilitating and include excessive vaginal bleeding, anemia, fatigue and lack of energy. According to Al-Hendy, women who suffer from uterine fibroids may lose time from work, have higher medical expenses and often need advanced medical treatment in order to become pregnant – all things that cause both emotional and economic hardship for families.

Al-Hendy and his team have conducted extensive research on the treatment of fibroid tumors and are dedicated to finding a cure for this disease which disproportionately affects African-American women who are four times more likely to be affected than women from other ethnic groups.

Researchers are in the process of recruiting participants for human trials that will begin soon.

The research will be conducted under the umbrella of the Meharry Clinical and Translational Research Center (MeTRC). In 2009, Meharry was awarded a $21.4 million grant from the National Center for Research Resources (NCRR) to establish MeTRC which will help accelerate the process of turning laboratory discoveries into actual cures and treatments used by patients.

MeTRC is a “center without walls” comprised of the Center for AIDS Health Disparities Research, the Center for Women’s Health Research and the Participant and Clinical Interactions Resource. Al-Hendy and Dr. James E.K. Hildreth serve as the principal investigators of this institutional grant.

About Meharry Medical College: Meharry Medical College is the nation’s largest private, independent, historically black academic health center dedicated solely to educating minority and other health professionals. True to its heritage, it is a United Methodist Church affiliated institution. The College is particularly well known for its uniquely nurturing, highly effective educational programs; emerging preeminence in health disparities research; culturally sensitive, evidence-based health services; and significant contribution to the diversity of the nation’s health professions workforce. Diverse Issues in Higher Education’s ranking of institutions annually lists Meharry as a leading national educator of African Americans with M.D. and D.D.S. degrees, and Ph.D. degrees in the biomedical sciences. Visit www.mmc.edu to learn more.

Contact:
Janet M. Caldwell: 615.500.0632
Cynthia Yeldell: 615.327.6986 or 615.280.0319

###

Read the full story at http://www.prweb.com/releases/Meharry_Medical_College/Uterine_Fibroid_Research/prweb3499084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. Researchers discover method to objectively identify PTSD
4. Researchers find a treatment for deadly brain tumor
5. Researchers find new insights into inherited retinal disease
6. Pitt researchers raise concern over frequency of surveillance colonoscopy
7. Stress triggers tumor formation, Yale researchers find
8. Johns Hopkins researchers say vaccine appears to mop up leukemia cells Gleevec leaves behind
9. St. Johns wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say
10. Young hunters most likely to be injured using tree stands, say UAB researchers
11. Researchers find clues to why some continue to eat when full
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
(Date:4/24/2017)... ... April 24, 2017 , ... Miami ... attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant ... will present its annual Global Symposium at the Fontainebleau Hotel located in Miami ...
(Date:4/24/2017)... ... April 24, 2017 , ... Anaconda BioMed, ... neuro-thrombectomy systems for the treatment of Acute Ischemic Stroke (AIS), today announced it ... as the product advances towards regulatory and clinical phases. , "This is another ...
(Date:4/23/2017)... ... April 23, 2017 , ... Altura ... the achievement of Cisco Select certification and SMB specialization. Altura is now ... , In earning the Select Certification, Altura fulfilled the training and exam ...
(Date:4/22/2017)... ... April 22, 2017 , ... PharmacyChecker.com released its first ... average of 70% when buying medication online from Canadian pharmacies verified in the ... from other countries. The report (chart below) compares U.S. and foreign prices for ...
(Date:4/21/2017)... ... April 21, 2017 , ... An April 10 article in the ... which reveal a great deal about prehistoric ice-age dental practitioners and their primitive and, ... used to remove decayed dental matter, and that teeth were then filled with bitumen, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
Breaking Medicine Technology: